Virginia Meca-Lallana

InstitutionHospital Universitario de La Princesa
AddressMadrid
Spain
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 4 publications in June 2020
    All Publications
    Bar chart showing 17 publications over 8 distinct years, with a maximum of 5 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Arrambide G, Llaneza-González MÁ, Costa-Frossard França L, Meca-Lallana V, Díaz EF, Moreno-Torres I, García-Domínguez JM, Ortega-Suero G, Ayuso-Peralta L, Gómez-Moreno M, Sotoca-Fernández JJ, Caminero-Rodríguez AB, Rodríguez de Antonio LA, Corujo-Suárez M, Otano-Martínez MA, Pérez-Miralles FC, Reyes-Garrido V, Ayuso-Blanco T, Balseiro-Gómez JJ, Muñoz-Pasadas M, Pérez-Molina I, Arnal-García C, Domingo-Santos Á, Guijarro-Castro C, Íñiguez-Martínez C, Téllez Lara N, Castellanos-Pinedo F, Castillo-Triviño T, Cerdán-Santacruz DM, Pérez-Sempere Á, Torres BS, Álvarez de Arcaya A, Costa-Arpín E, Durán-Ferreras E, Fragoso-Martínez M, González-Platas M, Landete Pascual L, Millán-Pascual J, Oreja-Guevara C, Meca-Lallana JE. SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry. Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(5). PMID: 34168057.
      Citations: 4     Fields:    Translation:Humans
    2. Costa Frossard-França L, García-Domínguez JM, Moreno-Torres I, Fortún J, Villar LM, Meca-Lallana V. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis]. Rev Neurol. 2021 04 01; 72(7):250-260. PMID: 33764494.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    3. Meca-Lallana V. COVID-19 will change MS care forever - Yes. Mult Scler. 2020 09; 26(10):1147-1148. PMID: 32567486.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    4. Meca-Lallana V, Aguirre C, Cardeñoso L, Alarcon T, Vivancos J. COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies. Mult Scler Relat Disord. 2020 Sep; 44:102306. PMID: 32585617.
      Citations: 20     Fields:    Translation:Humans
    5. Aguirre C, Meca-Lallana V, Barrios-Blandino A, Del Río B, Vivancos J. Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role? Mult Scler Relat Disord. 2020 Sep; 44:102250. PMID: 32531754.
      Citations: 14     Fields:    Translation:Humans
    6. Meca-Lallana V, Aguirre C, Cardeñoso L, Alarcon T, Figuerola-Tejerina A, Del Río B, Álvarez MR, Vivancos J. Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic. Mult Scler Relat Disord. 2020 09; 44:102244. PMID: 32544863.
      Citations: 2     Fields:    Translation:Humans
    7. Costa-Frossard L, Moreno-Torres I, Meca-Lallana V, García-Domínguez JM, En Representación Del Grupo de Estudio de Enfermedades Desmielinizantes de la Comunidad Autónoma de ERDGEEDCAM. [EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic]. Rev Neurol. 2020 05 01; 70(9):329-340. PMID: 32329046.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health